Major Healthcare Industry Customers Recommend I-OnAsia

Recent Testimonials Highlight Our Company's Strength In Sector

Major healthcare industry customers have stepped forward to offer testimonials in support of I-OnAsia's capabilities in due diligence, corporate investigations, and security services. The referrals were offered in response to requests for information from major global research institution, and have highlighted I-OnAsia's experience in the sector.

The professionals coming forward to attest to I-OnAsia's capabilities represent companies valued at over US$200 billion: Chief Security Officers of companies in personalized medicine, vaccines, treatments, and medical devices, as well as executives responsible for Compliance, Global Asset Protection, and Strategic Investments. These happy clients have decades of experience in the health care C-suite

I-OnAsia's longstanding experience in the sector includes work on behalf of payers and providers as well as key stakeholders within the wider care ecosystem. A significant portion of the work has focused on Intellectual Property Rights (IPR) protection, recently comprising: Dark Web and chat room monitoring for illegal sales of personal data and sensitive corporate information; independent and thorough investigations of employee theft of trade secrets; gray market sales and smuggling investigations touching on regulatory matters and not limited to the use of data analytics for customer validation and end-use reviews; and sample purchases. Another major portion of the work has been Enhanced Due Diligence, including: Standard media and public records research and verification; Industry and FCPA specific searches; and detailed in-person interviews and site visits. I-OnAsia has also provided a variety of Security Services focused on protecting valuable data.

Similar referrals have recently been offered by a other satisfied customers representing customers valued at over $400 billion, in adjacent Manufacturing and Chemicals and Technology sectors.

For more information, contact our team.

21 views0 comments